Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

This study is currently recruiting participants.
Verified April 2013 by Forest Laboratories
Sponsor:
Collaborator:
Gedeon Richter Ltd.
Information provided by (Responsible Party):
Forest Laboratories
ClinicalTrials.gov Identifier:
NCT01396447
First received: July 15, 2011
Last updated: April 30, 2013
Last verified: April 2013
  Purpose

The objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of patients with bipolar depression.


Condition Intervention Phase
Depression, Bipolar
Drug: Placebo
Drug: Cariprazine
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Double-blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar Depression

Resource links provided by NLM:


Further study details as provided by Forest Laboratories:

Primary Outcome Measures:
  • Montgomery-Asberg Depression Rating Scale (MADRS) [ Time Frame: Week 6 to Week 8 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Clinical Global Impressions - Severity (CGI-S) [ Time Frame: Week 6 to Week 8 ] [ Designated as safety issue: No ]

Estimated Enrollment: 600
Study Start Date: July 2011
Estimated Study Completion Date: November 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: 1
Placebo
Drug: Placebo
Patients who meet eligibility criteria will be administered a once daily oral dose of placebo
Experimental: 2
Cariprazine, 0.75 mg/day
Drug: Cariprazine
Patients who meet eligibility criteria will be administered a once daily oral dose of cariprazine
Experimental: 3
Cariprazine, 1.5 mg/day
Drug: Cariprazine
Patients who meet eligibility criteria will be administered a once daily oral dose of cariprazine
Experimental: 4
Cariprazine, 3.0 mg/day
Drug: Cariprazine
Patients who meet eligibility criteria will be administered a once daily oral dose of cariprazine

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients who have provided informed consent prior to any study specific procedures
  • Patients currently meeting the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for bipolar I disorder as confirmed by the Structured Clinical Interview for DSM-IV-TR (SCID) bipolar I depression without psychotic features
  • Patients with normal physical examination, laboratory, vital signs,and/ or ECG
  • Verified previous manic or mixed episode
  • Patients with a total Hamilton Rating Scale for Depression (HAMD)-17 score greater than or equal to 20
  • Patients with a HAMD-17 item 1 score greater than or equal to 2
  • Patients with a (Clinical Global Impression of Severity) CGI-S score of greater than or equal to 4

Exclusion Criteria:

  • Patients with a DSM-IV-TR diagnosis of an axis I disorder other than bipolar I disorder that was the primary focus of treatment within the previous six months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01396447

Contacts
Contact: Sandra Beaird, PhD 1-800-678-1605 ext 66297 info@forestpharm.com

  Hide Study Locations
Locations
United States, Alabama
Forest Investigative Site 021 Recruiting
Birmingham, Alabama, United States, 35216
United States, Arkansas
Forest Investigative Site 017 Terminated
Springdale, Arkansas, United States, 72764
United States, California
Forest Investigative Site 030 Recruiting
Beverly Hills, California, United States, 90210
Forest Investigative Site 018 Recruiting
Cerritos, California, United States, 90703
Forest Investigative Site 028 Recruiting
Costa Mesa, California, United States, 92626
Forest Investigative Site 015 Recruiting
Oceanside, California, United States, 92056
Forest Investigative Site 022 Active, not recruiting
San Diego, California, United States, 92123
Forest Investigative Site 011 Recruiting
Temecula, California, United States, 92591
United States, Colorado
Forest Investigative Site 002 Withdrawn
Aurora, Colorado, United States, 80045
United States, Florida
Forest Investigative Site 012 Recruiting
Jacksonville, Florida, United States, 32216
Forest Investigative Site 035 Recruiting
Orlando, Florida, United States, 32806
Forest Investigative Site 013 Active, not recruiting
Winter Park, Florida, United States, 32789
United States, Georgia
Forest Investigative Site 005 Recruiting
Atlanta, Georgia, United States, 30328
Forest Investigative Site 038 Recruiting
Atlanta, Georgia, United States, 30308
United States, Illinois
Forest Investigative Site 029 Completed
Chicago, Illinois, United States, 60640
United States, Indiana
Forest Investigative Site 024 Recruiting
Indianapolis, Indiana, United States, 46260
United States, Kansas
Forest Investigative Site 031 Recruiting
Prairie Village, Kansas, United States, 66208
United States, Louisiana
Forest Investigative Site 041 Recruiting
Lake Charles, Louisiana, United States, 70629
Forest Investigative Site 040 Recruiting
Shreveport, Louisiana, United States, 71104
United States, Maryland
Forest Investigative Site 001 Completed
Towson, Maryland, United States, 21204
United States, Mississippi
Forest Investigative Site 039 Recruiting
Flowood, Mississippi, United States, 39232
United States, Missouri
Forest Investigative Site 026 Recruiting
Creve Coeur, Missouri, United States, 63141
United States, Nevada
Forest Investigative Site 037 Recruiting
Las Vegas, Nevada, United States, 89102
United States, New Jersey
Forest Investigative Site 023 Recruiting
Cherry Hill, New Jersey, United States, 08002
Forest Investigative Site 014 Recruiting
Willingboro, New Jersey, United States, 08046
United States, New Mexico
Forest Investigative Site 006 Recruiting
Albuquerque, New Mexico, United States, 87109
United States, New York
Forest Investigative Site 003 Recruiting
Brooklyn, New York, United States, 11214
Forest Investigative Site 025 Recruiting
New York, New York, United States, 10021
United States, North Carolina
Forest Investigative Site 004 Completed
Durham, North Carolina, United States, 27710
United States, Ohio
Forest Investigative Site 036 Recruiting
Canton, Ohio, United States, 44718
Forest Investigative Site 008 Recruiting
Dayton, Ohio, United States, 45417
United States, Oregon
Forest Investigative Site 042 Recruiting
Salem, Oregon, United States, 98007
United States, Pennsylvania
Forest Investigative Site 009 Recruiting
Allentown, Pennsylvania, United States, 18104
Forest Investigative Site 010 Recruiting
Media, Pennsylvania, United States, 19063
United States, Rhode Island
Forest Investigative Site 033 Terminated
Lincoln, Rhode Island, United States, 02865
United States, Tennessee
Forest Investigative Site 019 Recruiting
Memphis, Tennessee, United States, 38119
United States, Texas
Forest Investigative Site 007 Recruiting
Dallas, Texas, United States, 75231
Forest Investigative Site 016 Recruiting
Houston, Texas, United States, 77008
Forest Investigative Site 027 Recruiting
Houston, Texas, United States, 77054
Forest Investigative Site 020 Recruiting
San Antonio, Texas, United States, 78229
Forest Investigative Site 034 Active, not recruiting
San Antonio, Texas, United States, 78229
United States, Washington
Forest Investigative Site 032 Recruiting
Seattle, Washington, United States, 98104
Argentina
Forest Investigative Site 213 Not yet recruiting
Banfield, Buenos Aires, Argentina, B1828CKR
Forest Investigative Site 203 Not yet recruiting
La Plata, Buenos Aires, Argentina, 1900
Forest Investigative Site 205 Not yet recruiting
La Plata, Buenos Aires, Argentina, 1900
Forest Investigative Site 204 Not yet recruiting
Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina, 1058
Forest Investigative Site 202 Not yet recruiting
Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina, 1181
Forest Investigative Site 211 Not yet recruiting
Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina, 1117
Forest Investigative Site 206 Not yet recruiting
Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina, C1405BCH
Forest Investigative Site 207 Not yet recruiting
Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina, 1117
Forest Investigative Site 209 Not yet recruiting
Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina, 1405
Forest Investigative Site 212 Not yet recruiting
Ciudad de Mendoza, Mendoza, Argentina, M5502AHV
Forest Investigative Site 201 Not yet recruiting
Buenos Aires, Argentina, C1425AHQ
Forest Investigative Site 208 Not yet recruiting
Cordoba, Argentina, X5009BIN
Forest Investigative Site 210 Not yet recruiting
Santiago del Estero, Argentina, 4200
Bulgaria
Forest Investigative Site 307 Recruiting
Kazanlak, Bulgaria, 6100
Forest Investigative Site 302 Recruiting
Pleven, Bulgaria, 5800
Forest Investigative Site 301 Recruiting
Plovdiv, Bulgaria, 4002
Forest Investigative Site 304 Not yet recruiting
Sofia, Bulgaria, 1606
Forest Investigative Site 305 Recruiting
Sofia, Bulgaria, 1431
Forest Investigative Site 306 Recruiting
Sofia, Bulgaria, 1431
Canada, Alberta
Forest Investigative Site 104 Completed
Medicine Hat, Alberta, Canada, T1B 4E7
Canada, British Columbia
Forest Investigative Site 102 Active, not recruiting
Kelowna, British Columbia, Canada, V1Y 1Z9
Forest Investigative Site 103 Recruiting
Penticton, British Columbia, Canada, V2A 4M4
Forest Investigative Site 105 Active, not recruiting
Victoria, British Columbia, Canada, V8R 4Z3
Canada, Ontario
Forest Investigative Site 106 Withdrawn
Burlington, Ontario, Canada, L7R 4E2
Forest Investigative Site 101 Recruiting
Chatham, Ontario, Canada, N7L1B7
Forest investigative Site 107 Terminated
Toronto, Ontario, Canada, M5T 2S8
Russian Federation
Forest Investigative Site 601 Recruiting
Arkhangelsk, Russian Federation, 163530
Forest Investigative Site 605 Recruiting
Moscow, Russian Federation, 107076
Forest Investigative Site 611 Recruiting
Moscow, Russian Federation, 117152
Forest Investigative Site 607 Recruiting
Moscow, Russian Federation, 115522
Forest Investigative Site 603 Recruiting
Nizhniy Novgorod, Russian Federation, 603107
Forest Investigative Site 612 Recruiting
Saint-Petersburg, Russian Federation, 197183
Forest Investigative Site 616 Recruiting
Saratov, Russian Federation, 410028
Forest Investigative Site 608 Recruiting
St. Petersburg, Russian Federation, 192019
Forest Investigative Site 615 Recruiting
St. Petersburg, Russian Federation, 192019
Forest Investigative Site 606 Recruiting
St. Petersburg, Russian Federation, 190121
Forest Investigative Site 613 Recruiting
St. Petersburg, Russian Federation, 197101
Forest Investigative Site 614 Not yet recruiting
St. Petersburg, Russian Federation, 192019
Forest Investigative Site 602 Recruiting
St. Petersburg, Russian Federation, 191119
Forest Investigative Site 604 Recruiting
St. Petersburg, Russian Federation, 190005
Forest Investigative Site 609 Recruiting
Tomsk, Russian Federation, 634015
Forest Investigative Site 610 Recruiting
Voronezh, Russian Federation, 394000
Ukraine
Forest Investigative Site 707 Recruiting
Kerch, AR Crimea, Ukraine, 98310
Forest Investigative Site 709 Recruiting
Kherson, Vil. Stepanivka, Ukraine, 73488
Forest Investigative Site 703 Recruiting
Kharkiv, Ukraine, 61068
Forest Investigative Site 702 Recruiting
Kharkiv, Ukraine, 61103
Forest Investigative Site 704 Recruiting
Kharkov, Ukraine, 61002
Forest Investigative Site 701 Recruiting
Kyiv, Ukraine, 4655
Forest Investigative Site 708 Recruiting
Kyiv, Ukraine, 2660
Forest Investigative Site 710 Recruiting
Odesa, Ukraine, 65014
Forest Investigative Site 706 Recruiting
Simferopol, Ukraine, 95006
Forest Investigative Site 705 Recruiting
Vinnitsa, Ukraine, 21005
Sponsors and Collaborators
Forest Laboratories
Gedeon Richter Ltd.
Investigators
Study Director: Robert Dunn, MD, PhD Forest Laboratories
  More Information

No publications provided

Responsible Party: Forest Laboratories
ClinicalTrials.gov Identifier: NCT01396447     History of Changes
Other Study ID Numbers: RGH-MD-56, 2011-002334-39
Study First Received: July 15, 2011
Last Updated: April 30, 2013
Health Authority: United States: Food and Drug Administration
Canada: Health Canada
Argentina: Ministry of Health
Bulgaria: Ministry of Health
Russia: Pharmacological Committee, Ministry of Health
Ukraine: Ministry of Health

Keywords provided by Forest Laboratories:
Bipolar I Disorder
Bipolar Depression
Depression
Bipolar Disorder

Additional relevant MeSH terms:
Bipolar Disorder
Depression
Depressive Disorder
Affective Disorders, Psychotic
Mood Disorders
Mental Disorders
Behavioral Symptoms

ClinicalTrials.gov processed this record on May 23, 2013